A new compound active against triple-negative breast cancer has been developed, which offers increased scientific understanding of this very aggressive cancer.
Poor oral health and poor dental care both increase the risk of oral cancer. Using mouthwash more than 3 times a day also increased the risk of mouth cancers.
Half of 415 prostate cancer cases, classified as "slow growing" before surgery via grading and staging, were found to be more aggressive post-operation.
Although treatment guidelines for high-risk bladder cancer include chemotherapy before or after surgery, it is not commonly used in routine clinical practice.
A man’s blood type may affect risk of prostate cancer recurrence after surgery. Specifically, patients with blood type "O" had a significantly decreased risk.
Moderate-to-severe obstructive sleep apnea was linked with 2.5 times higher likelihood of cancer, after adjustment for obesity and many other factors.
Data presented at the 2014 International Liver Congress focus on new approaches for improving diagnosis, staging & treatment of hepatocellular carcinoma (HCC).
A new non-invasive blood based test can detect breast cancer recurrence and may also predict treatment outcomes. It is based on 10 breast-cancer specific genes.
Young women treated with radiation for cervical cancer have increased risk of colorectal cancer. Therefore, they should begin screening earlier than normal.
The US FDA advises to avoid use of laparoscopic power "morcellation" (surgical division of mass) in hysterectomy & other procedures, as it warns of cancer risk.
Colorectal cancer risk from eating processed meat is significantly higher in 1 in 3 people who are carriers of a common gene variant, according to new research.
The FDA has approved ramucirumab (an angiogenesis inhibitor, trade name: "Cyramza") for treatment of advanced gastric cancer or gastroesophageal adenocarcinoma.
Women who eat a lot of fat (saturated fat in particular), may be at higher risk of certain breast cancer types, as per research on this controversial topic.
European regulators have recommended the drug Mekinist (trametinib) for approval as a treatment for unresectable or metastatic melanoma in certain patients.
Nearly 1 in 3 breast cancer survivors who were working when they began treatment, were unemployed 4 years later, especially if they received chemotherapy.
The US FDA has granted accelerated approval for ceritinib (trade name: Zykadia) for treatment of a less common subtype of non-small cell lung cancer (NSCLC).
Lamps for drying nail polish radiate UV-A, which can cause skin cancer. However, the exposure is brief and the risk remains small, according to researchers.
An experimental drug for metastatic pancreatic cancer improved the overall survival rate in patients, in combination with another two drugs, in a clinical trial.
Vitamin D levels has been tied to a number of health aspects. A new study suggests that low vitamin D levels can predict aggressive prostate cancer risk.
A new study indicates that sleep disruption may lead to weaker immune function or impaired hormonal stress responses. The mechanism remains unclear, however.
A new clinical trial shows that non-invasive magnetic resonance guided focused ultrasound treatment that heats the tumor within the bone relieves from pain.
The risk of divorce increases when the wife (but not the husband) becomes ill with a serious condition, like cancer. In a study, 31% of couples separated.
Low testosterone levels in low-risk prostate cancer patients may indicate worsening of their disease, leading doctors to prescribe more aggressive treatment.
Retreating lung tumors with radiation is an old idea that has been reintroduced, based on the technological advances in radiation oncology over the last decade.
A research team showed that timing the delivery of chemotherapy to the aggressive tumors dramatically shrinks lung and breast tumors, in a study.
Two validation studies show that a test can accurately predict response to chemoradiation therapy before surgery, in patients with esophageal adenocarcinoma.
A study found that patients with metastatic kidney cancer can tolerate and benefit from a treatment called high-dose interleukin-2 (HDIL-2) immunotherapy.
New data support the potential of cobimetinib combined with vemurafenib, for the treatment of metastatic melanoma, the most aggressive form of skin cancer.
Scientists have identified 17 "high-priority" chemicals that women should avoid in order to reduce risk of breast cancer, and show how to detect their presence.
A new study by researchers at Ohio State University provides evidence that genetically modifying immune cells might effectively treat multiple myeloma.